Uptake of Polygenic Risk Testing for Glaucoma in Unaffected Individuals

Key Points

• The uptake of polygenic risk testing is informed by specific predictors of interest.
• Key evidence points to effective clinical implementation strategies for glaucoma screening.
• Observational analysis highlights factors influencing acceptance of genetic testing in unaffected individuals.
• These findings may enable healthcare providers to tailor approaches to improve testing rates.